Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEEPBLOCK: Deep vs Moderate Neuromuscular Blockade in Laparoscopy
NCT03034577Phase 4Completed
- Sponsor
- University of Melbourne
- Start
- Jun 2017
- Primary completion
- Feb 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by University of Melbourne. Started Jun 2017; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03034577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03034577.